OTC Markets OTCPK - Delayed Quote USD

Ryman Healthcare Limited (RHCGF)

1.4100
0.0000
(0.00%)
As of March 27 at 9:31:10 AM EDT. Market Open.
Loading Chart for RHCGF
  • Previous Close 1.4100
  • Open 1.4100
  • Bid --
  • Ask --
  • Day's Range 1.4100 - 1.4100
  • 52 Week Range 1.4000 - 3.1000
  • Volume 92,585
  • Avg. Volume 595
  • Market Cap (intraday) 1.432B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3700
  • Earnings Date May 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 8, 2022
  • 1y Target Est --

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, as well as a care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.

www.rymanhealthcare.co.nz

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: RHCGF

View More

Performance Overview: RHCGF

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .

YTD Return

RHCGF
45.98%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
5.28%

1-Year Return

RHCGF
36.49%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
6.77%

3-Year Return

RHCGF
77.32%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
11.43%

5-Year Return

RHCGF
80.28%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
14.12%

Compare To: RHCGF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RHCGF

View More

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    1.27B

  • Enterprise Value

    2.82B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.35

  • Price/Book (mrq)

    0.56

  • Enterprise Value/Revenue

    6.60

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -57.42%

  • Return on Assets (ttm)

    -0.19%

  • Return on Equity (ttm)

    -10.07%

  • Revenue (ttm)

    760.69M

  • Net Income Avi to Common (ttm)

    -436.83M

  • Diluted EPS (ttm)

    -0.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.66M

  • Total Debt/Equity (mrq)

    39.78%

  • Levered Free Cash Flow (ttm)

    374.63M

Research Analysis: RHCGF

View More

Company Insights: RHCGF

Research Reports: RHCGF

View More

People Also Watch